Prestige Consumer Healthcare Inc (NYSE: PBH) has reported E.P.S. of $0.99 for its fourth fiscal quarter (ending March 31) versus $-4.83 for the same period a year ago. Relative to the consensus estimate of $1.14, this was a shortfall of $-0.15. For the latest four quarters through March 31, E.P.S. were $4.21 compared to $-1.65 a year ago.
Recent Price Action
Prestige Consumer Healthcare Inc (NYSE: PBH) stock closed at $71.47 on 5/14/24 after an increase of 1.4%. This advance was accompanied by normal trading volume. The stock has risen 2.1% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, PBH is expected to continue to be an important Value Builder.
Prestige Consumer Healthcare has a current Value Trend Rating of C (Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Prestige Consumer Healthcare has a slightly negative Appreciation Score of 38 but a slightly positive Power Rating of 69, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment